生物
表观遗传学
效应器
CD8型
祖细胞
免疫疗法
后生
转录调控
细胞生物学
细胞毒性T细胞
转录因子
癌症研究
遗传学
DNA甲基化
免疫学
免疫系统
癌症
干细胞
基因
基因表达
体外
作者
Jean‐Christophe Beltra,Sasikanth Manne,Mohamed S. Abdel-Hakeem,Makoto Kurachi,Josephine R. Giles,Zeyu Chen,Valentina Casella,Shin Foong Ngiow,Omar Khan,Yinghui Huang,Patrick Yan,Kito Nzingha,Wei Xu,Ravi K. Amaravadi,Xiaowei Xu,Giorgos C. Karakousis,Tara C. Mitchell,Lynn M. Schuchter,Alexander C. Huang,E. John Wherry
出处
期刊:Immunity
[Elsevier]
日期:2020-05-01
卷期号:52 (5): 825-841.e8
被引量:640
标识
DOI:10.1016/j.immuni.2020.04.014
摘要
CD8+ T cell exhaustion is a major barrier to current anti-cancer immunotherapies. Despite this, the developmental biology of exhausted CD8+ T cells (Tex) remains poorly defined, restraining improvement of strategies aimed at “re-invigorating” Tex cells. Here, we defined a four-cell-stage developmental framework for Tex cells. Two TCF1+ progenitor subsets were identified, one tissue restricted and quiescent and one more blood accessible, that gradually lost TCF1 as it divided and converted to a third intermediate Tex subset. This intermediate subset re-engaged some effector biology and increased upon PD-L1 blockade but ultimately converted into a fourth, terminally exhausted subset. By using transcriptional and epigenetic analyses, we identified the control mechanisms underlying subset transitions and defined a key interplay between TCF1, T-bet, and Tox in the process. These data reveal a four-stage developmental hierarchy for Tex cells and define the molecular, transcriptional, and epigenetic mechanisms that could provide opportunities to improve cancer immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI